Annals of Indian Academy of Neurology
GUIDELINES
Year
: 2011  |  Volume : 14  |  Issue : 5  |  Page : 18--20

Sleep disorders in Parkinson's disease: Diagnosis and management


 

Correspondence Address:




How to cite this article:
. Sleep disorders in Parkinson's disease: Diagnosis and management.Ann Indian Acad Neurol 2011;14:18-20


How to cite this URL:
. Sleep disorders in Parkinson's disease: Diagnosis and management. Ann Indian Acad Neurol [serial online] 2011 [cited 2019 Sep 20 ];14:18-20
Available from: http://www.annalsofian.org/text.asp?2011/14/5/18/83093


Full Text

A large majority (upto 96%) of patients with Parkinson's disease (PD) suffer from various sleep-related problems. [1],[2] Sleep disturbances, as assessed by validated scales like the Parkinson's disease sleep scale (PDSS) [3] usually correlate with disease severity and the Hoehn and Yahr staging. [4]

The main factors responsible for disturbed sleep in PD have been classified by Barone et al, into the following four subcategories: [5] 1) PD-related motor symptoms, including nocturnal akinesia, early-morning dystonia, painful cramps, tremor and difficulty turning in bed; 2) treatment-related nocturnal disturbances with drugs like levodopa, other dopamine agonists, antidepressants; 3) psychiatric symptoms, including hallucinations, vivid dreams, depression, dementia, insomnia, psychosis and panic attacks; 4) other sleep disorders, including insomnia, rapid eye movement behavioral disorder (REM-BD), restless legs syndrome (RLS), periodic leg movements (PLMS) and excessive daytime sleepiness (EDS). Other common problems among these patients like poor sleep hygiene, nocturia and pain further worsen sleep quality.

 Objective Assessment of PD Patients for Sleep Problems



Over the last few years, a bedside scale, the PDSS for sleep disturbances specifically for PD has been developed, validated and employed for screening. [3] The following sleep-related issues are included in this scale:



Overall quality of night's sleep (item 1)Sleep onset and maintenance insomnia (items 2 and 3)Nocturnal restlessness (items 4 and 5)Nocturnal psychosis (items 6 and 7)Nocturia (items 8 and 9)Nocturia motor symptoms (items 10-13)Sleep refreshment (item 14)Daytime dozing (item 15)

This, along with the widely accepted sleepiness scale, the Epworth Sleepiness Scale is an 'easy to apply' instrument for identifying sleep-related problems in PD. [6] In addition, for specific assessment for RBD, the RBD clinical questionnaire can be used. [7] [Table 1]{Table 1}

Diagnosis of individual sleep problems and their management

RLS and / or PLMD

RLS is diagnosed by specific criteria laid down by the international RLS study group: [8]

Essential Criteria:



Urge to move legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs.Symptoms begin or worsen during periods of rest or inactivity such as lying or sitting. Symptoms are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.Symptoms are worse in the evening or at night than during the day or only occur in the evening or night.

The diagnosis of PLMD can be suspected clinically, typically with the bed partner complaining of jerky limb movements occurring periodically every few seconds or minutes. This does, however, need to be confirmed through an overnight polysomnography. [9]

Treatment:

Although treatment strategies essentially remain the same for RLS and PLMD in PD as in other patients, with dopamine agonists and Levodopa, the main challenge often is to control symptoms, when patients are already on high doses of these agents for PD. Improvement of RLS symptoms following bilateral subthalamic nucleus stimulation in patients with PD, has been reported. [10]

RBD:

RBD is a disorder manifesting with elaborate motor activity with dream mentation during REM sleep with intermittent loss of REM sleep atonia. The following the diagnostic criteria laid down in the International Classification of Sleep disorders (ICSD-R) and criteria B and C are the minimal, required for RBD diagnosis: [11]



The patient has a complaint of violent or injurious behavior during sleep.Limb or body movement is associated with dream mentation.At least one of the following occurs:Harmful or potentially harmful sleep behaviors Dreams appear to be "acted out"Sleep behaviors disrupt sleep continuityPolysomnographic monitoring demonstrates at least one of the following electrophysiological measures during REM sleep:

Excessive augmentation of chin electromyography (EMG) toneExcessive chin or limb phasic EMG twitching, irrespective of chin EMG activity and one or more of the following clinical features during REM sleep:

Excessive limb or body jerkingComplex, vigorous or violent behaviors Absence of epileptic activity in association with the disorder

Upto half of all patients with RBD can progress to develop PD and other neurodegenerative conditions (multiple system atrophy, diffuse lewy body dementia) nearly 10-50 years after onset of RBD symptoms. [12],[13]

Treatment:

Treatment of RBD is relatively simple since a vast majority (>90%) of patients show good response to small doses (0.25-3 mg) of Clonazepam. [14] Another agent which can be useful is melatonin; however, the purity of available preparations of this drug remains an issue.

Sleep apnea

Studies have shown that sleep apnea is not commoner in patients with PD than in the general population. [15] However, this being a common disorder, especially in the elderly, who may also suffer from cardiovascular comorbidities. The diagnosis is suspected from a history of excessive snoring, excessive daytime somnolence and witnessed apneas and needs to be established by polysomnography studies.

Treatment, as in all patients with obstructive sleep apnea, is with continuous positive airway pressure (CPAP).

Disorders of circadian sleep rhythm

The main problems related to circadian sleep rhythms are irregular sleep wake patterns, mainly resulting from the widely prevalent problem of EDS in patients with PD, which results in multiple naps in the daytime and disrupted and inadequate nighttime sleep. Dopaminergic therapy has been shown to be related with activity rest rhythm alterations, mainly early morning awakenings among patients with PD. [16] The other rhythm disorder which could be encountered is advanced sleep phase syndrome, in which sleep onset shifts to much earlier than usual with very early morning awakening. This can result from an exaggeration of the propensity for the elderly to develop some advancement in sleep phase.

These problems can be addressed by stressing the need for proper sleep hygiene with fixed sleep schedules and minimal allowance for daytime napping.

Insomnia

Nearly 30% patients with PD may suffer from insomnia, resulting from the general tendency of the elderly to lose a continuous consolidated period of sleep every night, compounded by motor problems of PD, nocturia, medication effect, any other primary sleep disorders and most of all coexistent depression. [17]

Treatment should be targeted firstly toward improving physical activity with regular sleep schedules, improving sleep hygiene. Simultaneously, a good history should always be taken to look for primary sleep disorders and causes of secondary insomnia, mainly depression.

EDS

EDS in PD can be multifactorial. The various causes which may cause disrupted nighttime sleep, as discussed above should be the main target. Sleep apnea should especially be looked for.

The following table summarizes a brief approach toward diagnosis and management of sleep disorders:

References

1Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson's disease and sleep. Sleep Med Rev 2003;7:115-29.
2Happe S, Ludemann P, Berger K. The association between disease severity and sleep-related problems in patients with Parkinson's disease. Neuropsychobiology 2002;46:90-6.
3Chaudhari KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, et al. The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629- 35.
4Tse W, Liu Y, Barthlen GM, Hälbig TD, Tolgyesi SV, Gracies JM, et al. Clinical usefulness of the Parkinson's disease sleep scale. Parkinsonism Relat Disord 2005;11:317-21.
5Barone P, Amboni M, Vitale C. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 2004;26:S35-8.
6Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991;14:540-5.
7Scaglione C, Vignatelli L, Plazzi G, Marchese R, Negrotti A, Rizzo G, et al. REM sleep behaviour disorder in Parkinson's disease: A questionnaire-based study. Neurol Sci 2005;25:316-21.
8Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; et al. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
9Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, et al. Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep 2005;28:499-521.
10Driver-Dunckley E, Evidente VG, Adler CH, Hillman R, Hernandez J, Fletcher G, et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006;21:1287-9.
11American Academy of Sleep Medicine. International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. American Academy of Sleep Medicine, Rochester, Minnesota, 2001.
12Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurol 2006;5:572-7.
13Claassen DO, Josephs KA, Ahlskog JE. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010;75:494-9.
14Schenck CH, Mahowald MW. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with the REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleve Clin J Med 1990;57:S10-24.
15Trotti LM, Bliwise DL. No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord 2010;25:2246-9.
16Santiago PL, Rossi M, Cardinali DP, Merello M. Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy. Int J Neurosci 2010;120:11-6.
17Larsen JP, Tandberg E. Sleep disorders in patients with Parkinson's disease: Epidemiology and management. CNS Drugs 2001;15:267-75.